Display options
Share it on

Cancers (Basel). 2021 Nov 24;13(23). doi: 10.3390/cancers13235897.

Chromosome Imbalances in Neuroblastoma-Recent Molecular Insight into Chromosome 1p-deletion, 2p-gain, and 11q-deletion Identifies New Friends and Foes for the Future.

Cancers

Jikui Guan, Bengt Hallberg, Ruth H Palmer

Affiliations

  1. Department of Pediatric Oncology Surgery, Zhengzhou Key Laboratory of Precise Diagnosis and Treatment of Children's Malignant Tumors, Children's Hospital Affiliated to Zhengzhou University, Zhengzhou 450018, China.
  2. Department of Medical Biochemistry and Cell Biology, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, 40530 Gothenburg, Sweden.

PMID: 34885007 PMCID: PMC8657310 DOI: 10.3390/cancers13235897

Abstract

Neuroblastoma is the most common extracranial solid pediatric tumor, with around 15% childhood cancer-related mortality. High-risk neuroblastomas exhibit a range of genetic, morphological, and clinical heterogeneities, which add complexity to diagnosis and treatment with existing modalities. Identification of novel therapies is a high priority in high-risk neuroblastoma, and the combination of genetic analysis with increased mechanistic understanding-including identification of key signaling and developmental events-provides optimism for the future. This focused review highlights several recent findings concerning chromosomes 1p, 2p, and 11q, which link genetic aberrations with aberrant molecular signaling output. These novel molecular insights contribute important knowledge towards more effective treatment strategies for neuroblastoma.

Keywords: ALK; ALKAL2; DLG2; MYCN; PHOX2B; haploinsufficiency

References

  1. Cancer Discov. 2013 Jan;3(1):35-43 - PubMed
  2. N Engl J Med. 1999 Oct 14;341(16):1165-73 - PubMed
  3. Nat Commun. 2020 Feb 14;11(1):913 - PubMed
  4. J Clin Oncol. 2014 Sep 1;32(25):2727-34 - PubMed
  5. Nature. 2008 Oct 16;455(7215):930-5 - PubMed
  6. Genes Chromosomes Cancer. 2019 Jul 24;: - PubMed
  7. Elife. 2015 Sep 29;4:e09811 - PubMed
  8. Sci Adv. 2020 Jul 15;6(29):eaaz3440 - PubMed
  9. Cold Spring Harb Perspect Med. 2013 Oct 01;3(10):a014415 - PubMed
  10. Med Pediatr Oncol. 2001 Jan;36(1):32-6 - PubMed
  11. Proc Natl Acad Sci U S A. 2015 Dec 29;112(52):15862-7 - PubMed
  12. Nat Commun. 2021 Sep 7;12(1):5309 - PubMed
  13. Oncogene. 2012 Dec 13;31(50):5193-200 - PubMed
  14. EMBO J. 2021 Feb 1;40(3):e105784 - PubMed
  15. Cell Rep. 2020 Sep 22;32(12):108171 - PubMed
  16. Auton Neurosci. 2009 Nov 17;151(1):10-6 - PubMed
  17. BMC Genomics. 2008 Jul 29;9:353 - PubMed
  18. J Clin Oncol. 2009 Jan 10;27(2):289-97 - PubMed
  19. Clin Cancer Res. 2006 Jun 1;12(11 Pt 1):3368-73 - PubMed
  20. Science. 1984 Jun 8;224(4653):1121-4 - PubMed
  21. Sci Transl Med. 2012 Jul 4;4(141):141ra91 - PubMed
  22. Cell Rep. 2020 Jan 14;30(2):454-464.e5 - PubMed
  23. Nature. 2008 Oct 16;455(7215):975-8 - PubMed
  24. Cancer Res. 2011 Jan 1;71(1):98-105 - PubMed
  25. Nat Genet. 2017 Aug;49(8):1261-1266 - PubMed
  26. Nature. 2008 Oct 16;455(7215):971-4 - PubMed
  27. Science. 2017 Jul 7;357(6346): - PubMed
  28. Cancer Cell. 2012 Jul 10;22(1):117-30 - PubMed
  29. Int J Cancer. 2021 Oct 11;: - PubMed
  30. Biol Rev Camb Philos Soc. 2019 Oct;94(5):1774-1785 - PubMed
  31. Genesis. 2019 Oct;57(10):e23323 - PubMed
  32. Cell. 2010 Jun 25;141(7):1117-34 - PubMed
  33. Nat Genet. 2013 Mar;45(3):279-84 - PubMed
  34. Mol Cancer. 2017 Jun 29;16(1):114 - PubMed
  35. Nat Genet. 2013 Jan;45(1):12-7 - PubMed
  36. Nat Rev Genet. 2020 Jan;21(1):44-62 - PubMed
  37. Cell Commun Signal. 2020 Apr 20;18(1):65 - PubMed
  38. J Med Genet. 1980 Dec;17(6):477-8 - PubMed
  39. Proc Natl Acad Sci U S A. 2018 Jan 23;115(4):E630-E638 - PubMed
  40. J Biol Chem. 2013 Mar 22;288(12):8332-8341 - PubMed
  41. Lancet Oncol. 2003 Aug;4(8):472-80 - PubMed
  42. Surg Today. 2019 Sep;49(9):721-727 - PubMed
  43. Med Pediatr Oncol. 2001 Jan;36(1):24-7 - PubMed
  44. Nature. 1998 Nov 12;396(6707):177-80 - PubMed
  45. Science. 2012 Jun 22;336(6088):1578-81 - PubMed
  46. Proc Natl Acad Sci U S A. 2010 Mar 2;107(9):4323-8 - PubMed
  47. Oncogene. 2006 Feb 2;25(5):713-21 - PubMed
  48. Cancer. 2001 Nov 15;92(10):2699-708 - PubMed
  49. Nature. 2021 Dec;600(7887):143-147 - PubMed
  50. J Med Genet. 1997 Nov;34(11):949-51 - PubMed
  51. Acta Histochem. 2015 Oct;117(8):820-3 - PubMed
  52. Med Res Rev. 2021 Mar;41(2):961-1021 - PubMed
  53. Cancer Cell. 2012 Mar 20;21(3):362-73 - PubMed
  54. J Intern Med. 2018 Jan;283(1):16-44 - PubMed
  55. Biochem J. 2008 Dec 1;416(2):153-9 - PubMed
  56. Cell Tissue Res. 2018 May;372(2):287-307 - PubMed
  57. Proc Natl Acad Sci U S A. 2021 Feb 2;118(5): - PubMed
  58. Genes Chromosomes Cancer. 1993 May;7(1):32-7 - PubMed
  59. Jinrui Idengaku Zasshi. 1980 Mar;25(1):39-45 - PubMed
  60. Nature. 2008 Oct 16;455(7215):967-70 - PubMed
  61. Genome Res. 2020 Sep;30(9):1228-1242 - PubMed
  62. Nat Genet. 2015 Aug;47(8):864-71 - PubMed
  63. J Clin Oncol. 2009 Mar 1;27(7):1007-13 - PubMed
  64. Nat Rev Dis Primers. 2016 Nov 10;2:16078 - PubMed
  65. Mol Cancer Res. 2020 Dec;18(12):1759-1766 - PubMed
  66. Pigment Cell Melanoma Res. 2016 May;29(3):284-96 - PubMed
  67. Genes Dev. 2001 Nov 15;15(22):2934-9 - PubMed
  68. J Biol Chem. 2008 Sep 5;283(36):24426-34 - PubMed
  69. Oncogene. 1999 Sep 2;18(35):4948-57 - PubMed
  70. EMBO J. 1997 Jun 2;16(11):2985-95 - PubMed
  71. Proc Natl Acad Sci U S A. 2014 Nov 4;111(44):15741-5 - PubMed
  72. Med Pediatr Oncol. 2001 Jan;36(1):52-5 - PubMed
  73. Genes Chromosomes Cancer. 2015 Feb;54(2):99-109 - PubMed
  74. N Engl J Med. 2005 Nov 24;353(21):2243-53 - PubMed
  75. Nature. 2018 Mar 15;555(7696):321-327 - PubMed
  76. Cell Growth Differ. 1991 May;2(5):245-55 - PubMed
  77. Mol Cell Endocrinol. 2020 Dec 1;518:110998 - PubMed
  78. Front Oncol. 2020 May 05;10:670 - PubMed
  79. Am J Pathol. 2010 Jun;176(6):2616-25 - PubMed
  80. Lancet. 2007 Jun 23;369(9579):2106-20 - PubMed
  81. Cancer. 2017 Nov 1;123(21):4224-4235 - PubMed
  82. Oncogene. 2012 Nov 1;31(44):4667-76 - PubMed
  83. Oncotarget. 2014 May 15;5(9):2688-702 - PubMed
  84. Oncotarget. 2015 Jul 30;6(21):18558-76 - PubMed
  85. Neoplasia. 2001 Mar-Apr;3(2):105-9 - PubMed
  86. Cancer Res. 2013 Jan 15;73(2):776-84 - PubMed
  87. J Pediatr Hematol Oncol. 2006 Jun;28(6):379-82 - PubMed
  88. Genetics. 2008 Jun;179(2):737-46 - PubMed
  89. Pathol Oncol Res. 1997;3(1):3-7 - PubMed
  90. Curr Opin Genet Dev. 2017 Feb;42:81-90 - PubMed
  91. Int J Cancer. 2001 Mar 1;91(5):680-6 - PubMed
  92. Cancer Metastasis Rev. 2021 Mar;40(1):173-189 - PubMed
  93. Cancer Res. 2013 Jan 1;73(1):195-204 - PubMed
  94. Cancer Cell. 2020 Nov 9;38(5):716-733.e6 - PubMed
  95. Proc Natl Acad Sci U S A. 2017 Nov 7;114(45):12027-12032 - PubMed
  96. Cancer Res. 2008 Apr 15;68(8):2599-609 - PubMed
  97. Sci Rep. 2013 Dec 20;3:3450 - PubMed
  98. Clin Cancer Res. 2010 Sep 1;16(17):4353-62 - PubMed
  99. Neuropathology. 2006 Jun;26(3):165-9 - PubMed
  100. N Engl J Med. 2010 Jun 10;362(23):2202-11 - PubMed
  101. Cancer. 1977 Nov;40(5):2256-63 - PubMed
  102. J Pediatr Hematol Oncol. 2014 Apr;36(3):e193-6 - PubMed
  103. Genes Dev. 2008 Apr 1;22(7):884-93 - PubMed

Publication Types

Grant support